Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Sequencing Reagents Market, by Type
1.4.2 North America Sequencing Reagents Market, by Technology
1.4.3 North America Sequencing Reagents Market, by Application
1.4.4 North America Sequencing Reagents Market, by End Use
1.4.5 North America Sequencing Reagents Market, by Country
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.2.3 Market Opportunities
3.2.4 Market Challenges
Chapter 4. Competition Analysis - Global
4.1 KBV Cardinal Matrix
4.2 Recent Industry Wide Strategic Developments
4.2.1 Partnerships, Collaborations and Agreements
4.2.2 Product Launches and Product Expansions
4.2.3 Acquisition and Mergers
4.3 Market Share Analysis, 2023
4.4 Top Winning Strategies
4.4.1 Key Leading Strategies: Percentage Distribution (2020-2024)
4.4.2 Key Strategic Move: (Partnerships, Collaborations & Agreements: 2023, Feb – 2024, Apr) Leading Players
4.5 Porter Five Forces Analysis
Chapter 5. North America Sequencing Reagents Market by Type
5.1 North America Sequencing Kits Market by Country
5.2 North America Library Kits Market by Country
5.3 North America Control Kits Market by Country
5.4 North America Template Kits Market by Country
5.5 North America Other Type Market by Country
Chapter 6. North America Sequencing Reagents Market by Technology
6.1 North America Next-Generation Sequencing Market by Country
6.2 North America Third Generation Sequencing Market by Country
6.3 North America Sanger Sequencing Market by Country
Chapter 7. North America Sequencing Reagents Market by Application
7.1 North America Oncology Market by Country
7.2 North America Reproductive Health Market by Country
7.3 North America Clinical Investigation Market by Country
7.4 North America Agrigenomics & Forensics Market by Country
7.5 North America Consumer Genomics Market by Country
7.6 North America Other Application Market by Country
Chapter 8. North America Sequencing Reagents Market by End Use
8.1 North America Academic Research Market by Country
8.2 North America Clinical Research Market by Country
8.3 North America Hospitals & Clinics Market by Country
8.4 North America Pharmaceutical & Biotechnology Companies Market by Country
8.5 North America Other End Use Market by Country
Chapter 9. North America Sequencing Reagents Market by Country
9.1 US Sequencing Reagents Market
9.1.1 US Sequencing Reagents Market by Type
9.1.2 US Sequencing Reagents Market by Technology
9.1.3 US Sequencing Reagents Market by Application
9.1.4 US Sequencing Reagents Market by End Use
9.2 Canada Sequencing Reagents Market
9.2.1 Canada Sequencing Reagents Market by Type
9.2.2 Canada Sequencing Reagents Market by Technology
9.2.3 Canada Sequencing Reagents Market by Application
9.2.4 Canada Sequencing Reagents Market by End Use
9.3 Mexico Sequencing Reagents Market
9.3.1 Mexico Sequencing Reagents Market by Type
9.3.2 Mexico Sequencing Reagents Market by Technology
9.3.3 Mexico Sequencing Reagents Market by Application
9.3.4 Mexico Sequencing Reagents Market by End Use
9.4 Rest of North America Sequencing Reagents Market
9.4.1 Rest of North America Sequencing Reagents Market by Type
9.4.2 Rest of North America Sequencing Reagents Market by Technology
9.4.3 Rest of North America Sequencing Reagents Market by Application
9.4.4 Rest of North America Sequencing Reagents Market by End Use
Chapter 10. Company Profiles
10.1 Agilent Technologies, Inc.
10.1.1 Company Overview
10.1.2 Financial Analysis
10.1.3 Segmental and Regional Analysis
10.1.4 Research & Development Expense
10.1.5 Recent strategies and developments:
10.1.5.1 Acquisition and Mergers:
10.1.6 SWOT Analysis
10.2 F. Hoffmann-La Roche Ltd.
10.2.1 Company Overview
10.2.2 Financial Analysis
10.2.3 Segmental and Regional Analysis
10.2.4 Research & Development Expense
10.2.5 Recent strategies and developments:
10.2.5.1 Partnerships, Collaborations, and Agreements:
10.2.5.2 Product Launches and Product Expansions:
10.2.6 SWOT Analysis
10.3 Danaher Corporation (Beckman Coulter, Inc.)
10.3.1 Company Overview
10.3.2 Financial Analysis
10.3.3 Segmental and Regional Analysis
10.3.4 Research & Development Expense
10.3.5 SWOT Analysis
10.4 Abbott Laboratories
10.4.1 Company Overview
10.4.2 Financial Analysis
10.4.3 Segmental and Regional Analysis
10.4.4 Research & Development Expense
10.4.5 Recent strategies and developments:
10.4.5.1 Partnerships, Collaborations, and Agreements:
10.4.6 SWOT Analysis
10.5 Bio-Rad laboratories, Inc.
10.5.1 Company Overview
10.5.2 Financial Analysis
10.5.3 Segmental and Regional Analysis
10.5.4 Research & Development Expenses
10.5.5 Recent strategies and developments:
10.5.5.1 Partnerships, Collaborations, and Agreements:
10.5.5.2 Product Launches and Product Expansions:
10.5.6 SWOT Analysis
10.6 Quest Diagnostics Incorporated
10.6.1 Company Overview
10.6.2 Financial Analysis
10.6.3 Segmental Analysis
10.6.4 SWOT Analysis
10.7 Revvity, Inc.
10.7.1 Company Overview
10.7.2 Financial Analysis
10.7.3 Segmental and Regional Analysis
10.7.4 Research & Development Expenses
10.7.5 Recent strategies and developments:
10.7.5.1 Partnerships, Collaborations, and Agreements:
10.7.6 SWOT Analysis
10.8 Eurofins Scientific SE
10.8.1 Company Overview
10.8.2 Financial Analysis
10.8.3 Regional Analysis
10.8.4 Recent strategies and developments:
10.8.4.1 Partnerships, Collaborations, and Agreements:
10.8.5 SWOT Analysis
10.9 Hologic, Inc.
10.9.1 Company Overview
10.9.2 Financial Analysis
10.9.3 Segmental and Regional Analysis
10.9.4 Research & Development Expenses
10.9.5 Recent strategies and developments:
10.9.5.1 Acquisition and Mergers:
10.9.6 SWOT Analysis
10.10. Illumina, Inc.
10.10.1 Company Overview
10.10.2 Financial Analysis
10.10.3 Segment and Regional Analysis
10.10.4 Research & Development Expense
10.10.5 Recent strategies and developments:
10.10.5.1 Product Launches and Product Expansions:3
10.10.6 SWOT Analysis
Unique Offerings 